Atlas Trials

Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support

Clinical trial NCT05594342 · UNKNOWN

Trial details

NCT number
NCT05594342
Sponsor
The Young Investigator Group of Cardiovascular Research
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Heart FailureCardiogenic ShockIschemic Heart Disease
Start date
2022-07-01
Primary completion
2023-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.